Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim IntfiledCriticalBoehringer Ingelheim Int
Priority to UY29304ApriorityCriticalpatent/UY29304A1/en
Publication of UY29304A1publicationCriticalpatent/UY29304A1/en
La presente invención se refiere al uso de indolinonas de la fórmula general sustituidas en la posición 6, en las que de R1 a R6 y X se definen tal como en la reivindicación 1, sus isómeros y sales, en particular sus sales fisiológicamente aceptables, como medicamento para la prevención o el tratamiento de enfermedades fibróticas específicas.The present invention relates to the use of indolinones of the general formula substituted in position 6, wherein from R1 to R6 and X are defined as in claim 1, their isomers and salts, in particular their physiologically acceptable salts, as medicine for the prevention or treatment of specific fibrotic diseases.
UY29304A2005-12-222005-12-22
MEDICATIONS FOR THE TREATMENT OR PREVENTION OF FIBROTIC DISEASES
UY29304A1
(en)
Imidazolyl pyridine derived compounds linked to a heterocycle via a vinyl, modulators of amyloid-beta activity; pharmaceutical composition comprising said compounds; and its use for the treatment of diseases such as Alzheimer's, dementia, Down syndrome or amyloidosis.
Aryl-isoxasol-imidazole derived compounds; preparation procedure; pharmaceutical composition containing them; and use in the preparation of useful drugs in the treatment of cognitive disorders and Alzheimer's-related diseases.